results the probability was 7%, 8%/ 5%, and 50/0, respectively. The specificity of all tests in discriminating erosive from nonerosive RA at two years was low: 41%/
positive test result in the ELISAs for IgG, IgA, and IgM rheumatoid factor and the latex fixation test, was 17%, 27%, 40%, and 490/o, respectively; with negative test results the probability was 7%, 8%/ 5%, and 50/0, respectively. The specificity of all tests in discriminating erosive from nonerosive RA at two years was low: 41%/ 44%/ 47%0 and 58% for the ELISAs for IgG, IgA, and IgM rheumatoid factor and the latex fixation test, respectively. Conclusion-The ELISAs for IgG and IgA rheumatoid factor are of no significance in diagnosing RA and in the prediction of erosive disease. The ELISA for IgM rheumatoid factor is a reasonable alternative for the latex fixation test when age and gender are taken in to consideration. The specificity of all rheumatoid factor tests in discriminating erosive from nonerosive RA is low.
(Ann Rheum Dis 1996; 55: 157- 16 1)
The main role of rheumatoid factor in the clinical setting lies in its contribution to the diagnosis of rheumatoid arthritis (RA). The diagnostic value of the presence of rheumatoid factors has been studied most often for the classical latex fixation and Rose-Waaler agglutination assays; 1 however, little is known about the diagnostic properties of the enzyme linked immunosorbent assays (ELISAs)7 for quantitative detection of rheumatoid factor isotypes.
The results of rheumatoid factor tests are also used in making a prognosis in RA. In particular, the concentration of IgA rheumatoid factor is said to be useful in the prediction of bone erosions.8 There are considerable discrepancies, however, between the results of various studies concerning the prognostic value of rheumatoid factor isotypes.9 '7 In January 1989, the ELISA for rheumatoid factor isotypes was introduced for routine rheumatoid factor testing in the Department of Rheumatology of the Leiden University Hospital, The Netherlands, which is the only referral clinic for rheumatic disorders in a district of approximately 300 000 inhabitants. The latex fixation test remained in routine use as a standard until January 1992.
The objective of the present study was to determine the diagnostic and prognostic characteristics of the class specific ELISAs for rheumatoid factors and to compare them with those of the established latex fixation test.
Patients and methods
The medical records were reviewed of all patients (n = 1988) who first attended the outpatient clinic between January 1989 and October 1992, and who had blood removed for rheumatoid factor assays. Patients referred to the clinic for a second opinion were excluded. The following information was compiled from the medical charts: year of birth, gender, year of first visit to the outpatient clinic, time between onset of symptoms and first visit, time between first visit and first rheumatoid factor testing, first rheumatoid factor titres, clinical diagnosis, cumulative number of the revised 1987 American Rheumatism Association (ARA) criteria present,5 presence of typical bone erosions,5 18 time between first visit and onset of bone erosions, and period of clinical follow up. All rheumatoid factor tests had been performed within two months after the first visit to the outpatient clinic. The class specific rheumatoid factors had been measured by an ELISA using mouse monoclonal antibodies against human IgG, IgA, and IgM, recognising a defined epitope on the Fc part of the immunoglobulins, together with the biotin-streptavidin enhancement system as described previously. 7 In 34% of all eligible patients, rheumatoid factors had not been measured. Among this group, none had RA: 12-3% were diagnosed as having other inflammatory rheumatic diseases, 77.70 o as having non-inflammatory rheumatic disease, and 10-0% as having non-rheumatic disease.
The results of rheumatoid factor tests are usually taken into consideration when a clinical diagnosis of RA is made, which may lead to an overestimation of the diagnostic qualities of the tests. All analyses were therefore also performed using a diagnosis of RA based on the presence of four or more of the 1987 ARA criteria,5 excluding the rheumatoid factor criterion. On this basis, 91 patients were diagnosed as having RA, from 235 identified as having RA by the wider definition. Non-RA patients, positive RF test (%) Figure 1 Receiver operating characteristic curves of the different enzyme linked immunosorbent assay (ELISA) rheumatoidfactor (RF) tests used to discriminate rheumatoid arthritis (RA) (n = 235) from non-rheumatoid arthritis (non-RA) (n = 1753). The curves show the relation between true positive rate and false positive rate at different cut off titres. *Optimal cut off titre (IU).
The patients were stratified for age and gender to study the effect of these variables on rheumatoid factor positivity. For the analysis of the prognostic properties of the rheumatoid factor tests, we included only those RA patients who had been diagnosed as having RA according to the physician's opinion, whose disease was non-erosive at their first visit to the outpatient clinic, and who had been followed for at least two years (n = 62).
For all rheumatoid factor tests and their combinations at different cut off titres, the sensitivity, specificity, and accuracy (=sensitivity+ specificity/2) in discriminating RA patients from non-RA patients were calculated. To assess the ability of the rheumatoid factor tests to predict the development of bone erosions, their sensitivity, specificity, and accuracy in discriminating erosive RA from non-erosive RA after two years of follow up were calculated at different cut off titres. The results were presented graphically using receiver operating characteristic (ROC) curves, plotting the relation between true positive rate (sensitivity, y axis) and false positive rate (1 -specificity, x axis), for different cut off titres."9 Predictive values (=post-test probabilities) were calculated20 and presented graphically plotting the pretest probability on the x axis and the posttest probability on the y axis. The post-test probability represents the probability of a patient having RA, given a pretest probability (prevalence of RA) and the rheumatoid factor test result at a specific cut off titre.
Results

PATIENT CHARACTERISTICS
The patients were divided into two groups according to the diagnosis: group 1 consisted of those patients who had been diagnosed by the attending rheumatologist as having RA (n = 235); group 2 consisted of all other newly referred patients (non-RA) (n = 1753) comprising: patients with other inflammatory (n = 462) and non-inflammatory rheumatic disorders (n = 1138), and patients with nonrheumatic diseases (n = 153). Table 1 displays the demographic characteristics of the patient population (n = 1988) and the diagnostic subgroups. The median age of the RA patients was 13 years greater than that of the non-RA patients, and the median time between onset of symptoms and first clinic visit was six months for RA patients but twice as long for non-RA patients. The prevalence rate of RA in all patients who first attended the outpatient clinic was 6%; in the group of patients who had blood drawn for rheumatoid factor assays after selection by the physician it was 11 *8%. DIAGNOSTIC 
CHARACTERISTICS
The sensitivity and specificity of the rheumatoid factor assays in discriminating RA from non-RA patients are presented graphically for different cut off titres by means of ROC curves (fig 1) . The curves for the ELISAs for both IgG and IgA rheumatoid factor showed poor test Pretest probabil Figure 2 Post-test probability of rheumatoid arthri (upper bowed line) and after a negative test result (7 probabilities (=prevalence), using the optimal cut o1 enzyme linked immunosorbent assay (ELISA) rheu *Post-test probability ofRA at a clinical prevalence the physician). **Post-test probability ofRA at a cl (after selection by the physician).
characteristics E by the position greatest were chosen as optimal cut off titres. / <<' At the optimal cut off titre of 5 0 IU, the _ / // sensitivity of the ELISA for IgM rheumatoid // factor was 69'2% and the specificity 86O0%.
For the latex fixation test the sensitivity was 65-6% and the specificity 90 9% at the optimal cut off titre of 12-50 IU.
Both sensitivity and specificity, in particular _ / /// of the ELISA for IgM, decreased with 7 / // advancing age of the patient. Figure 1 Table 3 shows the prevalence of increased rheumatoid factors at at all cut off titres, as indicated optimal cut off titres in the four different of the curves near the 450 line. subgroups of patients.
Both the ELISA for IgM rheumatoid factor and the latex fixation test showed much better test characteristics. The rheumatoid factor titres at which the accuracy of the tests was 
PROGNOSTIC CHARACTERISTICS
For the analysis of the prognostic properties of the rheumatoid factor tests, 62 RA patients were included whose disease was non-erosive at their first clinic visit and who had been followed for at least two years. Seventeen patients with the same follow up time were excluded because they had erosions at the initial presentation. After two years of follow up, 30 patients had developed bone erosions, whereas 32 patients still had non-erosive disease. The erosive and non-erosive groups did not differ significantly in gender, or in age of the patient at first clinic visit. The median time between symptom onset and the first visit was slightly longer in the patients who developed erosions than in those who did not: 6-5 months (range 1-72) and 6-0 months (range 1-60), respectively. The sensitivity and specificity of the rheumatoid factor tests performed within two months after the first clinic visit, in discriminating erosive from non-erosive RA after two years of follow up, are presented graphically for different cut off titres by means of ROC curves (fig 3) . The test characteristics of the ELISAs for both IgG and IgA rheumatoid factor were poor; those of the ELISA for IgM rheumatoid factor and the latex fixation test were better, though the latter performed best: at the optimal cut off titre of 25-0 IU the sensitivity of the latex fixation test was 83-3% and the specificity 58-1% (fig 3) . 
Discussion
The present study has shown that the diagnostic characteristics of the ELISAs for both IgG and IgA rheumatoid factor in discriminating RA from non-RA are poor. The test characteristics of the ELISA for IgM rheumatoid factor and the latex fixation test proved to be much better, and compared reasonably well to each other, though the specificity of the latex fixation test was greater than that of the ELISA for IgM, resulting in a greater predictive value for a diagnosis of RA.
These results are partly in accordance with those of a previous study6 in which the latex fixation test was found to be a very specific test. The greater sensitivity and specificity of the latex fixation test found in that study can be explained by differences in patient selection, criteria for the diagnosis of RA, and study design. In an earlier Dutch study,7 a high specificity of the ELISA for all three rheumatoid factor isotypes was found. The selection of patients and controls, however, did not reflect clinical practice. The patients in that study were known to have had definite RA for some time, whereas patients in our study had early RA and were in a diagnostic phase; furthermore, selected patients with known systemic lupus erythematosus, ankylosing spondylitis, osteoarthritis, and bronchial asthma comprised the controls in the earlier study, but in the present study the controls consisted of all non-RA patients who first attended the outpatient clinic. The design of the present study, therefore, was more appropriate to the determination of the diagnostic qualities of the rheumatoid factor test. In an intervening study,21 a much lower specificity of the ELISA rheumatoid factor test was found when controls were selected randomly from the general population.
In that study also, the prevalence of the various rheumatoid factor isotypes in the control population seemed to vary with the age of the patient: IgM rheumatoid factor increased, and IgG rheumatoid factor decreased, with 21 age. In the present study, we found that the sensitivity and specificity of the ELISA for IgM decreased with advancing age of the patient, resulting in a greater diagnostic power of the ELISA for IgM in the younger age groups. For the latex fixation test, this effect of age was minimal. All rheumatoid factor assays had a greater sensitivity in men with RA compared with women patients, which is in accordance with the findings of other studies. 6 22 The diagnostic characteristics of the rheumatoid factor tests are in part dependent on the characteristics of the clinical population in which the test is used, such as the criteria for the definition of RA, age, gender, and the presence of other rheumatoid factor related diseases. 6 21 22 The test characteristics found in the present study will therefore not necessarily be in accordance with those observed in other clinic populations. However, the ratio of the diagnostic qualities of the different rheumatoid factor tests is not affected by these population characteristics, so that the IgM rheumatoid factor test can be accepted as being superior to the IgA and IgG tests. With regard to the prediction of erosions at two years, the discriminating qualities of the latex fixation test appeared to be better than those of the ELISAs for rheumatoid factor isotypes. In particular, the test characteristics of the ELISAs for IgG and IgA rheumatoid factor were poor. The specificity of all tests was low. In the literature, the results of cross sectional and longitudinal studies on the association between rheumatoid factor isotypes and the development of bone erosions are inconsistent.9-l7 This inconsistency may result from several factors such as differences in patient selection, study design, and the techniques used to measure the rheumatoid factor isotypes. In one study, only RA patients with negative agglutination assays were included.'2 The mean time between the onset of symptoms and the time of the first rheumatoid factor assay varied in the different studies and was sometimes more than two years. " 17 Furthermore, the follow up time in the various prospective studies varied from two to 10 years. In a Scandinavian study,'3 only radiographs of the hands were obtained, in contrast with most other studies in which radiographs of both hands and feet were assessed. In the present study, the rheumatoid factor tests were performed in all patients within two months after their first visit to the outpatient clinic, and radiographs of both hands and feet were assessed. Because of the limited time of follow up, no assessment of the severity of bone erosions could be made, which allowed us to discriminate only between erosive and nonerosive disease. A follow up period of two years is usually sufficient for the development of erosive disease. 23 In conclusion, the results of this study suggest that the diagnostic and prognostic qualities of the ELISAs for IgG and IgA rheumatoid factors for RA are poor, while the diagnostic qualities of the ELISA for IgM are much better, and comparable to those of the latex fixation test. When the ELISA for IgM is used as diagnostic test for RA, the influence of age and gender on rheumatoid factor positivity should be taken into consideration. Compared with the latex fixation test, the ELISA for rheumatoid factors is more reproducible, costs less, and is time saving, especially in larger clinics where large numbers of serum samples can be processed at the same time. In such a setting, therefore, the ELISA for IgM can replace the latex fixation test as the diagnostic test. The prognostic qualities of the latex fixation test are better than those of the Elisa for IgM, but still not good enough to provide guidelines for decisions concerning treatment. 
